Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Current Leases (2023 - 2025)

Maravai Lifesciences Holdings has reported Current Leases over the past 3 years, most recently at $876000.0 for Q2 2025.

  • Quarterly results put Current Leases at $876000.0 for Q2 2025, up 23.38% from a year ago — trailing twelve months through Jun 2025 was $876000.0 (up 23.38% YoY), and the annual figure for FY2024 was $792000.0, up 25.12%.
  • Current Leases for Q2 2025 was $876000.0 at Maravai Lifesciences Holdings, up from $834000.0 in the prior quarter.
  • Over the last five years, Current Leases for MRVI hit a ceiling of $876000.0 in Q2 2025 and a floor of $300000.0 in Q1 2023.
  • Median Current Leases over the past 3 years was $691000.0 (2024), compared with a mean of $672300.0.
  • Biggest five-year swings in Current Leases: skyrocketed 124.0% in 2024 and later increased 23.38% in 2025.
  • Maravai Lifesciences Holdings' Current Leases stood at $633000.0 in 2023, then increased by 25.12% to $792000.0 in 2024, then grew by 10.61% to $876000.0 in 2025.
  • The last three reported values for Current Leases were $876000.0 (Q2 2025), $834000.0 (Q1 2025), and $792000.0 (Q4 2024) per Business Quant data.